Prospective Interventional Clinical Trial of an MRI Based Patient Specific Focal Knee Resurfacing Implant (Episealer)

Universitaire Ziekenhuizen KU Leuven

Status: Active, not recruiting

Conditions: Focal Cartilage Lesions

Treatments: Other: Follow-up of Episealer implant

Study type: Interventional

Funder types: Other

Identifiers

NCT04808700

S57685

Details and patient eligibility

About

Lesions in the cartilage are common disorders. Arthroscopy lavage and debridement micro fracturing, mosaic plasticity as well as osteochondral autograft transplantation (OATS) are methods used for treatment of the lesions. Some have shown to help the patients but there is an ongoing treatment gap especially for patients with knee lesions and early osteoarthritis.

Episurf Medical has developed a Focal Knee Resurfacing (FKR) implant, the Episealer® implant. The implant is used for treatment of focal cartilage lesions of the lateral or medial femoral condyle in order to alleviate pain and improve range of motion.

In this study, the investigators aims to establish if this implant is a viable option for focal cartilage lesions of the distal femur not responding, or not eligible for, biological treatment options (eg. microfracturing)

Full description

Lesions in the cartilage are common disorders. In the knee, cartilage lesions are found in over 50 % of all arthroscopies, where 25 % of these are of focal character and the majority are found in the medial femoral condyle. The quality of life of patients with focal cartilage defects is significantly affected and it has been shown that the quality of life is affected to the same extend as in patients scheduled for knee replacement. Arthroscopy lavage and debridement micro fracturing, mosaic plasticity as well as osteochondral autograft transplantation (OATS) are methods used for treatment of the lesions. Some have shown to help the patients but there is an ongoing treatment gap especially for patients with knee lesions and early osteoarthritis.

Episurf Medical has developed a Focal Knee Resurfacing (FKR) implant, the Episealer® implant. The implant is used for treatment of focal cartilage lesions of the lateral or medial femoral condyle in order to alleviate pain and improve range of motion. The implant and surgical instruments are customized to each patient's joint anatomy, position, and size of injury, based on patient-specific images (MRI).

In this study, the investigators aims to establish if this implant is a viable option for focal cartilage lesions of the distal femur not responding, or not eligible for, biological treatment options (eg. microfracturing).

Enrollment: 8 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects with a focal cartilage lesion of the distal femur in which biological surgical methods have failed or are not eligible
• Minimal age of 18 years old (Preferred age group >40 years)
• Suitable for implant, to be determined by analysis of MRI imaging. Suitability is set by the size and location of the lesion. The maximum size of the lesion is set at 6cm².
• Informed consent obtained

Exclusion criteria

• Active or recent (<1 yr) septic arthritis of the involved knee
• Associated symptomatic untreated ligamentary or meniscal pathology in the involved knee
• (Severe) osteoarthritis in the involved or other compartments of the involved knee
• Severe osteoporosis
• MRI not possible (eg. due to pacemaker)
• Marked valgus- or varus alignment (>6 degrees)

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

8 participants in 1 patient group

Focal cartilage lesion

Other group

Description:

Patients with focal cartilage lesions who underwent a knee surgery using the Episealer implant

Treatment:

Other: Follow-up of Episealer implant